Uncovers the inflammatory role of Siglec-F+ neutrophils in C. difficile infection, suggesting new therapeutic targets.
Introduction Neutrophils exhibit a dual role in C. difficile infection (CDI), contributing to tissue homeostasis by containing pathogens while potentially causing tissue damage through excessive inflammatory mediator release. We identified a unique population of neutrophils expressing the eosinophil marker Siglec-F that rapidly accumulates in the colon during CDI. While Siglec-F+ neutrophils have been observed in other disease contexts, their specific role in CDI pathogenesis remains unclear. Methods We used CDI mouse models to characterize colon-infiltrating neutrophils. Flow cytometry and staining confirmed Siglec-F expression on mature neutrophils, distinguishing them from SiglecFhigh eosinophils. Functional depletion employed anti-Siglec-F antibodies in eosinophil-deficient mice. RNA sequencing compared gene expression profiles to identify differences. Further metabolic studies were done by using a Flow cytometry-based assay, SCENITH. Results We verified that Siglec-F+ cells are bona fide mature neutrophils distinct from eosinophils and other myeloid populations. These neutrophils demonstrated significant metabolic alterations (Glycolytic capacity, 5.153776494 %, 66.72 %) compared to conventional neutrophils. Depletion of Siglec-F+ neutrophils using anti-Siglec-F antibodies reduced CDI (p = 0.049) in eosinophil-deficient mice. RNA sequencing revealed that Siglec-F+ neutrophils exhibit enhanced phagocytic activity, increased extracellular trap formation, and elevated production of proinflammatory TH1-associated genes. Conclusion Siglec-F+ neutrophils represent a metabolically distinct neutrophil subset that contributes to CDI pathogenesis through enhanced inflammatory functions. Their depletion ameliorates disease severity, suggesting these cells play a detrimental role in CDI. This population may serve as a therapeutic target for managing severe CDI, as their unique metabolic profile and enhanced inflammatory capacity distinguish them from protective conventional neutrophils in the infected colon.
No takes yet. Share an insight, caveat, or question.
Naz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: